Review - Human urothelial carcinomas - A typical disease of the aged: The clinical utility of human chorionic gonadotrophin in patient management and future therapy

被引：11

作者：

Iles, RK ^{[1
]}

Butler, SA ^{[1
]}

机构：

[1] St Bartholomews Hosp, St Bartholomews & Royal London Sch Med & Dent, Williamson Lab Mol Oncol, London EC1A 7BE, England

来源：

EXPERIMENTAL GERONTOLOGY | 1998年 / 33卷 / 05期

关键词：

hCG beta; bladder cancer; prognosis; apoptosis; growth factor;

D O I：

10.1016/S0531-5565(98)00016-3

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

[No abstract available]

引用

页码：379 / 391

页数：13

共 68 条

[51] BLADDER-CANCER EPIDEMIOLOGY [J].

MATANOSKI, GM ;

ELLIOTT, EA .

EPIDEMIOLOGIC REVIEWS, 1981, 3 :203-229

[52] SERUM AND URINARY LEVELS OF BETA-HUMAN CHORIONIC-GONADOTROPIN IN PATIENTS WITH TRANSITIONAL CELL-CARCINOMA [J].

MCLOUGHLIN, J ;

PEPERA, T ;

BRIDGER, J ;

WILLIAMS, G .

BRITISH JOURNAL OF CANCER, 1991, 63 (05) :822-824

[53] Different hCG assays to measure ectopic hCG secretion in bladder carcinoma patients [J].

Mora, J ;

Gascon, N ;

Tabernero, JM ;

RodriguezEspinosa, J ;

GonzalezSastre, F .

BRITISH JOURNAL OF CANCER, 1996, 74 (07) :1081-1084

[54] IS BETA-HUMAN CHORIONIC-GONADOTROPIN PRODUCTION BY TRANSITIONAL-CELL CARCINOMA OF THE BLADDER A MARKER OF AGGRESSIVE DISEASE AND RESISTANCE TO RADIOTHERAPY [J].

MOUTZOURIS, G ;

YANNOPOULOS, D ;

BARBATIS, C ;

ZAHAROF, A ;

THEODOROU, C .

BRITISH JOURNAL OF UROLOGY, 1993, 72 (06) :907-909

[55]

NISHIMURA R, 1995, CANCER RES, V55, P1479

[56] METABOLIC-FATE OF HUMAN CHORIO-GONADOTROPIN [J].

NISULA, BC ;

BLITHE, DL ;

AKAR, A ;

LEFORT, G ;

WEHMANN, RE .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 33 (4B) :733-737

[57] TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder [J].

Pectasides, D ;

Bafaloucos, D ;

Antoniou, F ;

Gogou, L ;

Economides, N ;

Varthalitis, J ;

Dimitriades, M ;

Kosmidis, P ;

Athanassiou, A .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03) :271-277

[58]

RODENBURG CJ, 1985, ARCH PATHOL LAB MED, V109, P1046

[59]

SHAH VM, 1986, ARCH PATHOL LAB MED, V110, P107

[60]

SHAH VM, 1987, BRIT J EXP PATHOL, V68, P871

← 1 2 3 4 5 6 7 →